The "Chart of the Day" is Quest Diagnostics (DGX), which showed up on Thursday's Barchart "12-Month High" list. DGX on Thursday rallied by 1.40% and posted a new 1-1/2 year high of $60.23.

Enter your short position between $185.00 (the intra-day high of its last bearish candlestick) and $187.92 (the upper band of its horizontal resistance zone).Market Index Analysis Quest Diagnostics ...

Secaucus, NJ, Jan. 30, 2018 -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today that its ChartMaxx® enterprise content management ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Quest Diagnostics (DGX) reports results for the quarter ended September 2025. While this widely-known consensus ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Goal to combine Ultima’s highly sensitive, low-cost technology with Quest’s oncology expertise and national scale in order to improve patient access, affordability and outcomes FREMONT, Calif & ...